How has Perspective Therapeutics's goodwill impairment losses changed year-over-year?

Perspective Therapeutics's goodwill impairment losses decreased by 100.0% year-over-year, from $24.1M to $0.

Perspective Therapeutics CATX Goodwill impairment losses

Goodwill impairment losses at other companies

ZymeworksZYME

——

Other financials

Income statement

See full

Revenue$2.2M+27.3%

Gross profit$738.0K+78.3%

Operating income-$28.3M-29.5%

Net income-$26.2M-44.1%

EPS (diluted)-$0.250.0%

Balance sheet

See full

Cash & equivalents$54.0M+21.5%

Total debt$4.2M+10.9%

Total equity$347.4M+22.1%

Total assets$410.8M+24.7%

Cash flow

See full

Operating cash flow-$31.5M-45.8%

CapEx$6.9M+47.3%

Free cash flow-$38.3M-46.1%

Valuation

See full

Market cap$342.14M+33.2%

Enterprise value$292.34M+35.2%

P/S34.2×+19.6×

Profitability

See full

Gross margin33.1%-7.1pp

Operating margin-292.7%-553pp

Net margin-218.4%-781pp

FCF margin-1,073.3%—

Returns & leverage

See full

Return on equity-35.2%+2.3pp

Debt / equity0×0.0×

Current ratio8.7×-8.3×

Where this comes from

Reported directly by Perspective Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:GoodwillImpairmentLoss.

The official record: Perspective Therapeutics’s 10-K, filed March 16, 2026, on SEC EDGAR. View the filing →

Ask your AI about Perspective Therapeutics's goodwill impairment losses.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Perspective Therapeutics's goodwill impairment losses?: Perspective Therapeutics (CATX) reported goodwill impairment losses of $0 in Q4 2025.
How has Perspective Therapeutics's goodwill impairment losses changed year-over-year?: Perspective Therapeutics's goodwill impairment losses decreased by 100.0% year-over-year, from $24.1M to $0.